Making Real World Evidence Less 'Messy' To Help With Drug Pricing

 
• By Brenda Sandburg
  
FTI real world evidence Panel
Mark Nagy, Eli Lilly; Susan Shiff, Merck; Clive Meanwell, The Medicines Co. • Source: Photo by Brenda Sandburg
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access